Who’s Hired? Stada Names New Specialty Head
As Hyloris And Slayback Also Reveal New Appointments
Executive Summary
Stada has appointed a new specialty head who will have global responsibility for the firm’s biosimilars business. Meanwhile, Hyloris has named a new business development chief and a generics industry veteran has joined Slayback’s board.
You may also be interested in...
Stada Recruits Ex-Sandoz Exec To Help Steer Biosimilars
Stada has announced the appointment of former Sandoz executive Christine Berndt as head of global development for specialty and biosimilar products, replacing Michael Mack.
Who’s Hired? Stada Appoints New Biosimilars Head
Stada has welcomed former Novo Nordisk executive Erin Federman into its ranks as she steps into the role of global commercial head of biosimilars. Organizations such as the Association for Accessible Medicines, Granules India, Synthon, Taro and Mayne have also appointed new senior staff members in recent months.
Wagner Adds Germany To Role As Stada Simplifies Structure
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.